Live Breaking News & Updates on Guofeng Cheng

Stay updated with breaking news from Guofeng cheng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AusperBio Announces Major Progress in AHB-137 Clinical Development

/PRNewswire/ AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (Together AusperBio), a clinical-stage biotechnology company dedicated to advancing. ....

United States , New Zealand , Chris Yang , Ausper Biopharma Co Ltd , Prnewswire Ausperbio Therapeutics Inc , Bio Therapeutics , Together Ausperbio , Guofeng Cheng , Relations Contact , Ausperbio Therapeutics Inc ,

AusperBio Welcomes Dr. Will Wei as Head of CMC

/PRNewswire/ AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (Together AusperBio), a clinical-stage biotechnology company committed to advancing. ....

United States , Scripps Research Institute , University Of Lausanne , Department Of Organic Chemistry , Prnewswire Ausperbio Therapeutics Inc , Ausper Biopharma Co Ltd , Bio Therapeutics , Together Ausperbio , Will Wei , Guofeng Cheng , Senior Director , Norganic Chemistry , Scripps Research , Ausperbio Therapeutics Inc ,

AusperBio Announces IND Approval from China CDE for HBV ASO AHB-137

/PRNewswire/ AusperBio Therapeutic, Inc. and Ausper Biopharma Co., Ltd. (Together AusperBio), a clinical-stage biotech company announced that the Center for. ....

New Zealand , United States , Cheng Yong Yang , Ausper Biopharma Co Ltd , Prnewswire Ausperbio Therapeutic Inc , Bio Therapeutic , Together Ausperbio , Drug Evaluation , Investigational New Drug , Guofeng Cheng , Ausperbio Therapeutics Inc ,

AusperBio Announces IND Approval from China CDE for HBV ASO AHB-137

SAN FRANCISCO, June 28, 2023 /PRNewswire/ AusperBio Therapeutic, Inc. and Ausper Biopharma Co., Ltd. (Together AusperBio), a clinical-stage bio. ....

New Zealand , United States , Cheng Yong Yang , Ausper Biopharma Co Ltd , Prnewswire Ausperbio Therapeutic Inc , Bio Therapeutic , Together Ausperbio , Drug Evaluation , Investigational New Drug , Guofeng Cheng ,

AusperBio to Present Two Posters on AHB-137, a Novel Antisense Oligonucleotide for Hepatitis B at EASL™ Congress 2023

/PRNewswire/ Ausper Biopharma Co., Ltd. And AusperBio Therapeutic, Inc. (Together AusperBio), a clinical-stage biotechnology company, today announces the. ....

United States , Ausper Biopharma , Chris Yang , Tingting Lu , D Ausper Biopharma , Xiaoli Wu , International Liver Congress , Ausperbio Therapeutic Inc , Prnewswire Ausper Biopharma Co Ltd , Ausperbio Therapeutic , Together Ausperbio , European Association , Guofeng Cheng ,